Reviews
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
D. Saygin1, S. Glaubitz2, R. Zeng3, M. Bottai4, M. De Visser5, M.M. Dimachkie6, D. Fiorentino7, I. Gerhardson8, M. Kuwana9, F.W. Miller10, M. Needham11, L.G. Rider12, Y. Salem13, S. Schlüter14, S.K. Shinjo15, G. Wang16, V.P. Werth17, R. Aggarwal18, I.E. Lundberg19
- Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, PA, USA.
- Department of Neurology, University Medical Center Göttingen, Germany.
- Department of Neurology, University Medical Center Göttingen, Germany.
- Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
- Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
- Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA.
- Patient Research partner, Stockholm, Sweden.
- Department of Allergy and Rheumatology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
- Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
- Department of Neurology, Fiona Stanley Hospital, IIID Murdoch University and University of Notre Dame, Perth, Australia.
- Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
- Physical Therapy Program, Hofstra University, Hemstead, NY, USA.
- Diagnosegruppe Myositis, Deutsche Gesellschaft für Muskelkranke, Freiburg, Germany.
- Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, Brazil.
- Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Beijing, China.
- Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, and Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA.
- Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, PA, USA. aggarwalr@upmc.edu
- Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm; and Department of Gastroenterology, Dermatology and Rheumatology, Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.
CER17253
2024 Vol.42, N°2
PI 0403, PF 0412
Reviews
Free to view
(click on article PDF icon to read the article)
PMID: 38436279 [PubMed]
Received: 30/10/2023
Accepted : 22/01/2024
In Press: 28/02/2024
Published: 14/03/2024
Abstract
The 2017 EULAR/ACR classification criteria for adult/juvenile idiopathic inflammatory myopathies (IIM) were established using a data-driven approach by an international group of myositis experts to allow classification of IIM and its major subtypes. Since their publication, the performance of the criteria has been tested in multiple cohorts worldwide and significant limitations have been identified. Moreover, the understanding and classification of IIM have evolved since 2017. This scoping review was undertaken as part of a large international project to revise the EULAR/ACR criteria and aims to i) summarise the evidence from the current literature on the performance characteristics of the 2017 EULAR/ACR classification criteria in various cohorts and IIM subtypes, and ii) delineate the factors that need to be considered in the revision of the classification criteria. A systematic search of Medline (via PubMed), Cumulative Index to Nursing and Allied Health Literature, and conference abstract archives was conducted independently by three investigators for studies on the EULAR/ACR criteria published between October 2017 and January 2023. This scoping review of 19 articles and 13 abstracts revealed overall good performance characteristics of the EULAR/ACR criteria for IIM, yet deficiencies in lack of inclusion of certain IIM subtypes, such as immune mediated necrotising myopathy, amyopathic dermatomyositis, antisynthetase syndrome and overlap myositis. Published modifications that may improve the performance characteristics of the criteria for classification of IIM subtypes were also summarised. The results of this review suggest that a revision of the EULAR/ACR criteria is warranted.
